β¨ Fisheries and Health Notices
26 APRIL
NEW ZEALAND GAZETTE
953
Product Name:
Thrane & Thrane Inmarsat-C Mobile Earth Station transceiver
Manufacturer:
Thrane & Thrane A/S Denmark
Model No.:
TT3022D
Software Version No.:
Capsat Version 3.24 Non-SOLAS Fishery, which is comprised of the following:
- DTE Version: Capsat Version 3.03 (97-11-01)
- DTE Forms: MAF FORMS
- DCE Version: Capsat Version 3.24 (Jun 18 1999)
- Grant of type approvalβPursuant to regulation 5 (3) of the Fisheries (Satellite Vessel Monitoring) Regulations 1993, a provisional type approval has been granted to the following Inmarsat-C device to 30 September 2001:
Product Name:
Sailor Inmarsat-C Mobile Earth Station transceiver
Manufacturer:
Thrane & Thrane A/S Denmark
Model No.:
H1622D
Software Version No.:
Capsat Version 3.24 Non-SOLAS Fishery, which is comprised of the following:
- DTE Version: Capsat Version 3.03 (97-11-01)
- DTE Forms: MAF FORMS
- DCE Version: Capsat Version 3.24 (Jun 18 1999)
Dated at Wellington this 24th day of April 2001.
D. J. WOOD, National Manager Compliance. In exercise of delegated authority.
go2966
Health
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Aspartate β Glutamate
Active Ingredient(s):
Monosodium glutamate 228mmol/L
Sodium aspartate 228mmol/L
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Biomed Limited
Manufacturer(s):
Biomed Limited, Pt Chevalier, Auckland
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 23rd day of April 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2974
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Alpha-Amoxi
Active Ingredient(s):
Amoxycillin (trihydrate) 31.2854mg/mL equivalent to 25mg/mL anhydrous amoxycillin
Dosage Form:
Granules for oral suspension
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India
Product:
Alpha-Amoxi
Active Ingredient(s):
Amoxycillin (trihydrate) 62.5708mg/mL equivalent to 50.0mg/mL anhydrous amoxicillin
Dosage Form:
Granules for oral suspension
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer(s):
Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India
Product:
Lovir
Active Ingredient(s):
Aciclovir 250mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer(s):
Biologici Italia Laboratoires Srl, Novate Milanese, Milan, Italy
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 43
Gazette.govt.nz —
NZ Gazette 2001, No 43
β¨ LLM interpretation of page content
πΎ
Fisheries (Automatic Location Communicator) Notice 2001 (No. 1)
(continued from previous page)
πΎ Primary Industries & Resources24 April 2001
Fisheries, Satellite Vessel Monitoring, Automatic Location Communicator, Inmarsat-C, Type Approval
- D. J. Wood, National Manager Compliance
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare23 April 2001
Medicines Act 1981, Provisional Consent, Aspartate-Glutamate, Solution for infusion
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare23 April 2001
Medicines Act 1981, Consent, Alpha-Amoxi, Lovir, Amoxycillin, Aciclovir
- G. R. Boyd, Chief Advisor, Safety and Regulation